Significant reductions in COVID-19 infections found after single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine

Significant reductions in COVID-19 infections found after single dose of Oxford-AstraZeneca and Pfizer-BioNTech vaccine

COVID-19 infections fell significantly—by 65% percent—after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study.

Comments are closed.

Rare side effects from COVID vaccines may have been seen in 15 year old animal studies
23 April 2021
India’s staggering COVID crisis: Government dropped its guard too soon
23 April 2021